Status
Conditions
Treatments
About
This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Subject age ≥ 18 and ≤ 90 years at the time of screening
The subject has an LV ejection fraction of < 50% (within 90 days of index procedure) AND is at high-risk due to any of the following:
Unprotected left main coronary artery stenosis disease
Last remaining epicardial native coronary artery
Significant three vessel coronary artery disease
Significant two vessel coronary artery disease of complex lesions
Significant single vessel coronary artery disease of complex lesions and non-treated CTO
Target vessel is a CTO with planned retrograde approach
Intended calcium modification (by atherectomy, lithotripsy or laser)
Local heart team (interventional cardiologist, cardiac surgeon) has determined that the subject is an appropriate candidate for a PCI supported with a Mechanical Circulatory Support (MCS) System
Confirmed access site vasculature greater than 5.5 mm as measured by CT or femoral duplex ultrasound
The subject is willing and able to comply with the protocol-specified treatment and follow-up evaluations
The subject has been informed of the nature of the trial, agrees to its provisions, and has provided written informed consent approved by the appropriate Institutional Review Board (IRB) or Ethics Committee (EC)
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
310 participants in 2 patient groups
Loading...
Central trial contact
Darin R. Lerew
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal